News Wire

Hospitals and doctors’ offices nationwide might have avoided $1.7 billion in malpractice costs––and nearly 2,000 patient deaths––if medical staff and patients communicated better, according to an article posted on the STAT website. A report from CRICO Strategies, a research and analysis offshoot…
The Centers for Medicare and Medicaid Services (CMS) has issued proposed rules that would update the methods used to calculate the benchmarks of accountable care organizations (ACOs) that continue their participation in the Medicare Shared Savings Program (MSSP) after an initial three-year agreement…
Positive overall survival (OS) results have been reported from a pivotal phase 3 trial comparing cabozantinib (Cometriq, Exelixis, Inc.) and everolimus (Afinitor, Novartis) in patients with advanced renal cell carcinoma (RCC) who had experienced disease progression after treatment with a vascular epithelial…
Researchers at the Mayo Clinic in Arizona and at Banner Sun Health Research Institute have determined that testing a portion of a person’s submandibular gland may be a way to diagnose early Parkinson’s disease (PD). The study was published in Movement Disorders. Currently, no accurate diagnostic…
Positive results have been reported from a phase 2a clinical study of hydrocortisone acetate (HA) and lidocaine hydrochloride (LH) as single agents and in combination (HA/LH) in patients with grade I or II hemorrhoids. If the combination cream is eventually approved by the FDA, it would be the first…
There’s no reason to suspect Zika will be much different from dengue fever, and those outbreaks in the U.S. have largely been locally contained, according to Dr. Jared Aldstadt, an associate professor of geography at the University of Buffalo. Aldstadt’s research focuses on the mosquito species…
In response to recent infections and deaths from tainted medical scopes, U.S. lawmakers are wrestling with how to keep other dangerous devices from harming patients, according to a report from Kaiser Health News (KHN). Members of Congress, federal officials, and health-policy experts agree that the…
A new study investigating how hospitals try to avoid unnecessary emergency admissions has identified a series of innovations that could help to address the problem. Researchers in the United Kingdom have investigated how the emergency departments and staff of four major hospitals in the southwest of…
Positive data from a phase 3 pivotal study of defibrotide (Jazz Pharmaceuticals), a deoxyribonucleic acid derivative, have been published online in Blood, the journal of the American Society of Hematology. The findings demonstrated that treatment with defibrotide in patients with hepatic veno-occlusive…
In a new paper published in Nature, researchers describe a novel sweat monitor embedded on a translucent bracelet. The monitor consists of a sensor array and a flexible circuit board that measures the concentration of various chemicals in sweat, as well as a Bluetooth transmitter that beams the data…
The FDA has approved Onzetra Xsail (sumatriptan nasal powder, Avanir Pharmaceuticals), formerly known as AVP-825, for the acute treatment of migraine with or without aura in adults. The product is an intranasal medication delivery system consisting of a low dose (22 mg) of sumatriptan powder that is…
The Centers for Disease Control and Prevention (CDC) has dedicated an emergency operations center staffed around the clock to address the threat from Zika, a mosquito-borne virus linked to severe birth defects in thousands of babies in Brazil, agency officials told Reuters. The CDC set up such command…
In a new report, the American Hospital Association (AHA) states that centers must cut down on paperwork and other bureaucratic exercises that can cause health care costs to mount. The group suggests that hospitals convert many of these processes to an electronic format, particularly with regard to verification…
The FDA has approved eribulin mesylate (Halaven, Eisai), a form of chemotherapy, for the treatment of unresectable or metastatic liposarcoma, a type of soft-tissue sarcoma (STS). The treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug. STS is a disease…
The FDA has approved elbasvir and grazoprevir (Zepatier, Merck) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adults. Hepatitis C is a viral disease that causes inflammation of the liver, which can lead to diminished liver function or…

Pages